A Study of SHR-1501 Combination With BCG Versus Placebo Combined With BCG in Subjects With Papillary-Only NMIBC

Clinical trial NCT07726992 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07726992
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Papillary-Only Non-muscle-invasive Bladder Cancer

Start date: 2026-07-01
Primary completion: 2029-12-01
Enrollment: 750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.